Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
S D Med ; 77(3): 102-106, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38990793

ABSTRACT

This report discusses the case of a 54-year-old woman with a complex psychiatric history including schizophrenia, tardive dyskinesia, borderline intellectual function, and congenital deafness that reported auditory and visual hallucinations during an acute exacerbation of schizophrenia. After resuming a previous lithium regimen and introducing olanzapine, the patient improved and was discharged without hallucinations. In our report we explore some of the challenges we faced, discuss similar cases, and examine the unresolved debate about whether congenitally deaf patients can experience auditory hallucinations.


Subject(s)
Antipsychotic Agents , Deafness , Hallucinations , Schizophrenia , Humans , Female , Schizophrenia/complications , Hallucinations/etiology , Middle Aged , Deafness/complications , Antipsychotic Agents/therapeutic use , Olanzapine/therapeutic use , Benzodiazepines/therapeutic use
2.
S D Med ; 77(1): 31-35, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38986146

ABSTRACT

This case report presents an occurrence of three generalized seizures within 30 minutes of ingestion of lysergic acid diethylamide (LSD) in a 15-year-old female patient with treatment-resistant depressive disorder recently started on low-dose lithium therapy. She had no personal or family history of seizure, brain injury or other neurological disorder. The patient had a history of monthly LSD use on several occasions in the setting of ongoing fluoxetine and longacting bupropion (Wellbutrin XL) treatment, with seizures occurring only after initiation of lithium. Although the definitive causal link cannot be established, this case report suggests an increased seizure risk with combination of LSD and lithium, even at subtherapeutic serum lithium levels. This case emphasizes the need for further research, careful clinical practice, and patient education regarding the potential dangers of using psychedelic substances with psychopharmacological treatment.


Subject(s)
Lysergic Acid Diethylamide , Seizures , Humans , Female , Adolescent , Lysergic Acid Diethylamide/adverse effects , Seizures/chemically induced , Seizures/drug therapy , Hallucinogens/adverse effects , Hallucinogens/administration & dosage , Depressive Disorder, Treatment-Resistant/drug therapy
3.
Telemed J E Health ; 30(1): 166-172, 2024 01.
Article in English | MEDLINE | ID: mdl-37294586

ABSTRACT

Purpose: Diabetes remains a prevalent metabolic chronic condition. The pandemic promoted the use of telemedicine for patients with chronic conditions. Telemedicine offers innovative methods to achieve glycemic control for these patients. This study evaluates the effectiveness of telemedicine with pharmacists in reduction of glycated hemoglobin (A1C) for patients with diabetes. Methods: This study (n = 112) was a single-center, retrospective study that evaluated the effectiveness of patients enrolling in pharmacist-led diabetes management utilizing telemedicine during the COVID-19 pandemic. Patients with an A1C >9 mg/dL were contacted for telemedicine with the pharmacy team. The three groups included: patients agreeing to the telemedicine visit (n = 28), patients that declined the telemedicine visit (n = 42), and patients that did not answer the telephone when offered the telemedicine visit (n = 28). Results: Our study revealed a significant change in the primary endpoint A1C (2.6 + 2.4, p = 0.0144) for the patients who accepted telemedicine visits when compared with the other study groups. The secondary endpoints, changes in A1C (when evaluating employment status, number of clinic visits, number of chronic conditions, gender, race) and changes in body mass index, revealed no significant changes. Conclusion: Diabetes management using telemedicine with pharmacists impacts glycemic control in patients with type 2 diabetes. This study demonstrates patients who accepted pharmacist-led telemedicine had a reduction in A1C. Further research may reveal long-term benefits on clinical outcomes after utilizing this service during the COVID-19 pandemic.


Subject(s)
COVID-19 , Diabetes Mellitus, Type 2 , Telemedicine , Humans , Diabetes Mellitus, Type 2/therapy , Diabetes Mellitus, Type 2/complications , Glycated Hemoglobin , Pharmacists , Pandemics , Retrospective Studies , COVID-19/epidemiology , Chronic Disease
4.
Microsyst Nanoeng ; 9: 3, 2023.
Article in English | MEDLINE | ID: mdl-36597510

ABSTRACT

The COVID-19 pandemic has posed enormous challenges for existing diagnostic tools to detect and monitor pathogens. Therefore, there is a need to develop point-of-care (POC) devices to perform fast, accurate, and accessible diagnostic methods to detect infections and monitor immune responses. Devices most amenable to miniaturization and suitable for POC applications are biosensors based on electrochemical detection. We have developed an impedimetric immunosensor based on an interdigitated microelectrode array (IMA) to detect and monitor SARS-CoV-2 antibodies in human serum. Conjugation chemistry was applied to functionalize and covalently immobilize the spike protein (S-protein) of SARS-CoV-2 on the surface of the IMA to serve as the recognition layer and specifically bind anti-spike antibodies. Antibodies bound to the S-proteins in the recognition layer result in an increase in capacitance and a consequent change in the impedance of the system. The impedimetric immunosensor is label-free and uses non-Faradaic impedance with low nonperturbing AC voltage for detection. The sensitivity of a capacitive immunosensor can be enhanced by simply tuning the ionic strength of the sample solution. The device exhibits an LOD of 0.4 BAU/ml, as determined from the standard curve using WHO IS for anti-SARS-CoV-2 immunoglobulins; this LOD is similar to the corresponding LODs reported for all validated and established commercial assays, which range from 0.41 to 4.81 BAU/ml. The proof-of-concept biosensor has been demonstrated to detect anti-spike antibodies in sera from patients infected with COVID-19 within 1 h. Photolithographically microfabricated interdigitated microelectrode array sensor chips & label-free impedimetric detection of COVID-19 antibody.

5.
J Pharm Pract ; 36(4): 900-904, 2023 Aug.
Article in English | MEDLINE | ID: mdl-35465688

ABSTRACT

The COVID-19 pandemic has had a significant impact on communities across the United States (US). Three vaccines have now been granted Emergency Use Authorization by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) for use in the US. However, barriers to vaccination exist, some of which are well documented in the literature, including lack of knowledge, fear, accessibility, mistrust in the healthcare system, and systemic and operational obstacles. Vaccine hesitancy in the US could potentially hinder all the efforts and resources being used to beat COVID-19, which has resulted in more than 594 000 deaths in the US per the CDC as of early June 2021. In order to overcome this pandemic, vaccine distribution and uptake is crucial. Pharmacists play a crucial role as healthcare providers as they can dismantle vaccine hesitancy and make an outstanding impact on the efforts to overcome this pandemic.


Subject(s)
COVID-19 Vaccines , COVID-19 , United States/epidemiology , Humans , COVID-19/epidemiology , COVID-19/prevention & control , Pandemics , Health Personnel , Pharmacists
6.
S D Med ; 76(12): 534-541, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38986118

ABSTRACT

Substance use remains a critical concern in youth, necessitating early educational interventions to encourage informed decision-making. This study aimed to evaluate the effectiveness of a pilot health promotion and substance use prevention curriculum introduced at the third-grade level. Third-grade students from nine schools in South Dakota and Minnesota participated, with the curriculum's efficacy assessed via pre- and post-curriculum surveys evaluating students' knowledge of content included in the curriculum. Mean student age was 8.5 years old and average class size was 20 students. Results showed an increased understanding of basic substance use disorder concepts, an improved ability to identify different parts of the brain and identify harmful effects of substance use on the brain and body, and increased awareness of fentanyl as a dangerous substance. The differences between the pre-curriculum and post-curriculum were statistically significant, indicating learned concepts from the provided course content. This study highlights that a well-structured curriculum can bolster third graders' understanding about personal health, brain functions, safe medication use, and the potential harms from substance use.


Subject(s)
Curriculum , Health Knowledge, Attitudes, Practice , Substance-Related Disorders , Humans , Pilot Projects , Substance-Related Disorders/prevention & control , Female , Male , South Dakota , Child , Minnesota , Health Promotion/methods , Health Education/methods
7.
Science ; 361(6398): 174-177, 2018 07 13.
Article in English | MEDLINE | ID: mdl-29853552

ABSTRACT

Rising oceanic and atmospheric oxygen levels through time have been crucial to enhanced habitability of surface Earth environments. Few redox proxies can track secular variations in dissolved oxygen concentrations around threshold levels for metazoan survival in the upper ocean. We present an extensive compilation of iodine-to-calcium ratios (I/Ca) in marine carbonates. Our record supports a major rise in the partial pressure of oxygen in the atmosphere at ~400 million years (Ma) ago and reveals a step change in the oxygenation of the upper ocean to relatively sustainable near-modern conditions at ~200 Ma ago. An Earth system model demonstrates that a shift in organic matter remineralization to greater depths, which may have been due to increasing size and biomineralization of eukaryotic plankton, likely drove the I/Ca signals at ~200 Ma ago.


Subject(s)
Atmosphere/chemistry , Biological Evolution , Oxygen/analysis , Plankton , Calcium/analysis , Carbonates/analysis , Iodine/analysis , Oceans and Seas
SELECTION OF CITATIONS
SEARCH DETAIL
...